NCT00774384View on ClinicalTrials.gov

Regulation of Mucosal Immune Response to Systemic MenB Vaccine

PHASE2CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Meningococcal Infections
Interventions
BIOLOGICAL

NZ MenB OMV vaccine (NZ98/254)

3 doses by intramuscular injection

Trial Locations (2)

BS2 8HU

UBHT, Bristol

Unknown

North Bristol NHS Trust, Bristol

Sponsors

Collaborators (1)

Novartis Vaccines
All Listed Sponsors
collaborator

University of Bristol

OTHER

collaborator

Public Health England

OTHER_GOV

collaborator

Novartis Vaccines

INDUSTRY

collaborator

North Bristol NHS Trust

OTHER

lead

University Hospitals Bristol and Weston NHS Foundation Trust

OTHER